UBS Group
DCTH icon

UBS Group’s Delcath Systems DCTH Stock Holding History

UBS Group’s Portfolio DCTH Stock Details DCTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$525K Sell
41,714
-27,425
-40% -$303K ﹤0.01% 6192
2026
Q1 		$642K Sell
69,139
-129,853
-65% -$1.26M ﹤0.01% 5891
2025
Q4 		$2.01M Buy
198,992
+84,161
+73% +$837K ﹤0.01% 4977
2025
Q3 		$1.23M Buy
114,831
+57,940
+102% +$647K ﹤0.01% 5380
2025
Q2 		$774K Buy
56,891
+24,030
+73% +$335K ﹤0.01% 5661
2025
Q1 		$418K Buy
32,861
+12,204
+59% +$173K ﹤0.01% 5991
2024
Q4 		$249K Buy
20,657
+19,136
+1,258% +$202K ﹤0.01% 6319
2024
Q3 		$13.7K Sell
1,521
-7,881
-84% -$68.4K ﹤0.01% 7573
2024
Q2 		$78.7K Buy
9,402
+8,604
+1,078% +$54.5K ﹤0.01% 6349
2024
Q1 		$3.81K Buy
798
+795
+26,500% +$3.43K ﹤0.01% 7697
2023
Q4 		$12 Buy
3
+1
+50% +$3 ﹤0.01% 9106
2023
Q3 		$8 Sell
2
-21
-91% -$98 ﹤0.01% 9239
2023
Q2 		$134 Sell
23
-805
-97% -$5.05K ﹤0.01% 8458
2023
Q1 		$4.76K Sell
828
-2,470
-75% -$11K ﹤0.01% 8149
2022
Q4 		$11.9K Buy
3,298
+3,295
+109,833% +$10.1K ﹤0.01% 8343
2022
Q3 		$0 Hold
3
– – ﹤0.01% 10432
2022
Q2 		$0 Hold
3
– – ﹤0.01% 10412
2022
Q1 		$0 Sell
3
-1,478
-100% -$9.91K ﹤0.01% 10357
2021
Q4 		$11K Buy
1,481
+451
+44% +$4.26K ﹤0.01% 8662
2021
Q3 		$11K Buy
1,030
+1,028
+51,400% +$10.1K ﹤0.01% 7873
2021
Q2 		$0 Sell
2
-1,037
-100% -$11.9K ﹤0.01% 9446
2021
Q1 		$13K Buy
1,039
+1,038
+103,800% +$19.1K ﹤0.01% 7731
2020
Q4 		$0 Sell
1
-1,039
-100% -$14.2K ﹤0.01% 8449
2020
Q3 		$12K Buy
1,040
+464
+81% +$5.18K ﹤0.01% 6691
2020
Q2 		$6K Buy
+576
New +$4.65K ﹤0.01% 7287

Other funds holding DCTH

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AG
Algert Global San Francisco, California $8.43B AUM 80.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group's DCTH Position: Q2 2026 in Review

UBS Group reduced its Delcath Systems (DCTH) stake by 40% in Q2 2026, selling an estimated $303K and leaving 41,714 shares worth $525K. The position accounts for ﹤0.01% of the portfolio, ranked #6192.

UBS Group first reported a position in DCTH in Q2 2020 and has held it in 25 quarters since. The position peaked at $2.01M in Q4 2025. 120 funds tracked by Wall St. Rank hold DCTH as of Q2 2026.

  • UBS Group held 41,714 shares of Delcath Systems worth $525K as of Q2 2026.
  • UBS Group sold 27,425 Delcath Systems shares in Q2 2026, an estimated $303K.
  • Delcath Systems made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6192 holding.
  • UBS Group first reported a position in Delcath Systems in Q2 2020 and has held it in 25 quarters since.
  • UBS Group's Delcath Systems position peaked at $2.01M in Q4 2025.
  • 120 funds tracked by Wall St. Rank held Delcath Systems as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.